Back to Journals » Journal of Pain Research » Volume 12

Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review

Authors Kopsky DJ, Bhaskar AK, Zonneveldt HJ, Keppel Hesselink JM

Received 4 December 2018

Accepted for publication 18 February 2019

Published 29 April 2019 Volume 2019:12 Pages 1189—1192

DOI https://doi.org/10.2147/JPR.S196927

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr E Alfonso Romero-Sandoval


DJ Kopsky,1 AK Bhaskar,2 HJ Zonneveldt,3 JM Keppel Hesselink4

1Institute for Neuropathic Pain, Amsterdam, the Netherlands; 2Pain Management Centre, Charing Cross Hospital Imperial Healthcare NHS Trust, London, UK; 3Anesthesiology and Pain Department, Westfriesgasthuis, Hoorn, the Netherlands; 4Institute for Neuropathic Pain, Bosch en Duin, the Netherlands

Abstract: Peripheral nerve damage can result in neuronal hyperexcitability, resulting in neuropathic pain. Localized neuropathic pain is confined to a specific area not larger than a letter-size piece of paper. Topical analgesics are increasingly popular for the treatment of localized neuropathic pain because systemic agents for managing neuropathic pain often produce undesirable and intolerable side effects. Commonly used agents for topical use are amitriptyline, baclofen, ketamine and lidocaine; however, these agents do not always give the desired analgesic effect in some patients. We report for the first time a patient with chronic idiopathic axonal polyneuropathy and intractable localized neuropathic pain treated successfully with loperamide 5% cream. After application of loperamide 5% cream, the patient reported a complete reduction of pain within 30 mins, lasting for 2.5 hrs. Subsequently, the patient was able to reduce his daily intake of oxycodone, while using topical loperamide for pain relief. Loperamide is a nonprescription opioid agonist, commonly used against diarrhea. As a topical formulation, it is preferable over other opioids due to its low systemic bioavailability and low risk of crossing the blood–brain barrier. Peripheral upregulation and sensitization of opioid receptors at peripheral nerve endings and perhaps at other cell populations in the epidermis might be targets of topical loperamide.

Keywords: localized neuropathic pain, loperamide, topical agents, analgesia


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]